These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36166741)

  • 1. Effects of the Methylation Levels for the Breast Cancer Associated Genes
    Li J; Li P; Li J; Yang H; Liu G; Shen P; Jiang G
    Genet Test Mol Biomarkers; 2022 Sep; 26(9):422-429. PubMed ID: 36166741
    [No Abstract]   [Full Text] [Related]  

  • 2. BCSG1 siRNA delivered by lentiviral vector suppressed proliferation and migration of MDA-MB-231 cells.
    He JS; Xie N; Yang JB; Guan H; Chen WC; Zou C; Ouyang YW; Mao YS; Luo XY; Pan Y; Fu L
    Int J Mol Med; 2018 Mar; 41(3):1659-1664. PubMed ID: 29286089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCSG1 methylation status and BCSG1 expression in breast tissues derived from Chinese women with breast cancer.
    Gu YM; Tan JX; Lu XW; Ding Y; Han X; Sun YJ
    Oncology; 2008; 74(1-2):61-8. PubMed ID: 18544996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of BCSG1-siRNA in tumor transplants of human breast cancer cell line in nude mice].
    Shen PH; Zhang W; Zhang YH; Zhang HX; Fan QX
    Zhonghua Bing Li Xue Za Zhi; 2010 Oct; 39(10):691-4. PubMed ID: 21176537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms for aberrant expression of the human breast cancer specific gene 1 in breast cancer cells: control of transcription by DNA methylation and intronic sequences.
    Lu A; Gupta A; Li C; Ahlborn TE; Ma Y; Shi EY; Liu J
    Oncogene; 2001 Aug; 20(37):5173-85. PubMed ID: 11526506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of AP1 transactivation abrogates the abnormal expression of breast cancer-specific gene 1 in breast cancer cells.
    Lu A; Zhang F; Gupta A; Liu J
    J Biol Chem; 2002 Aug; 277(35):31364-72. PubMed ID: 12072430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of breast cancer specific gene 1 in the prognosis of breast cancer].
    Wu KJ; Weng ZY; Lin GF; Wu XR; Li FM; Zhang YC
    Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(5):294-7. PubMed ID: 15842935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory mechanisms for abnormal expression of the human breast cancer specific gene 1 in breast cancer cells.
    Lu A; Li Q; Liu J
    Sci China C Life Sci; 2006 Aug; 49(4):403-8. PubMed ID: 16989287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of BCSG1 with specific siRNA via nanocarriers for breast cancer treatment.
    Yang C; Cheng X; Shen P
    Bull Cancer; 2021 Mar; 108(3):323-332. PubMed ID: 33423781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin induces re‑expression of BRCA1 and suppression of γ synuclein by modulating DNA promoter methylation in breast cancer cell lines.
    Al-Yousef N; Shinwari Z; Al-Shahrani B; Al-Showimi M; Al-Moghrabi N
    Oncol Rep; 2020 Mar; 43(3):827-838. PubMed ID: 32020216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1.
    Gupta A; Inaba S; Wong OK; Fang G; Liu J
    Oncogene; 2003 Oct; 22(48):7593-9. PubMed ID: 14576821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing.
    Ji H; Liu YE; Jia T; Wang M; Liu J; Xiao G; Joseph BK; Rosen C; Shi YE
    Cancer Res; 1997 Feb; 57(4):759-64. PubMed ID: 9044857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA Interference Induces
    Shi Y; Huang R; Zhang Y; Feng Q; Pan X; Wang L
    Cancer Biother Radiopharm; 2024 Aug; 39(6):406-424. PubMed ID: 35180362
    [No Abstract]   [Full Text] [Related]  

  • 14. Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region.
    Magdinier F; Ribieras S; Lenoir GM; Frappart L; Dante R
    Oncogene; 1998 Dec; 17(24):3169-76. PubMed ID: 9872332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
    Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
    Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
    Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
    Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA1 Promoter Methylation and Clinicopathological Characteristics in Sporadic Breast Cancer Patients in Indonesia.
    Harahap WA; Sudji IR; Nindrea RD
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2643-2649. PubMed ID: 30256562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-slice spiral CT evaluation of breast cancer chemotherapy and correlation between CT results and breast cancerspecific gene 1.
    Li J; Gao W; Yu B; Wang F; Wang L
    J BUON; 2018; 23(2):378-383. PubMed ID: 29745080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative detection of methylation of FHIT and BRCA1 promoters in the serum of ductal breast cancer patients.
    Liu L; Sun L; Li C; Li X; Zhang Y; Yu Y; Xia W
    Biomed Mater Eng; 2015; 26 Suppl 1():S2217-22. PubMed ID: 26406001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1 expression status in relation to DNA methylation of the BRCA1 promoter region in sporadic breast cancers.
    Niwa Y; Oyama T; Nakajima T
    Jpn J Cancer Res; 2000 May; 91(5):519-26. PubMed ID: 10835497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.